169 related articles for article (PubMed ID: 25093492)
1. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes.
Hagberg KW; McGlynn KA; Sahasrabuddhe VV; Jick S
Br J Cancer; 2014 Oct; 111(9):1710-7. PubMed ID: 25093492
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
Koro CE; Bowlin SJ; Weiss SR
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):697-703. PubMed ID: 15654719
[TBL] [Abstract][Full Text] [Related]
3. New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer.
Lu Y; García Rodríguez LA; Malgerud L; González-Pérez A; Martín-Pérez M; Lagergren J; Bexelius TS
Br J Cancer; 2015 Dec; 113(11):1607-14. PubMed ID: 26575601
[TBL] [Abstract][Full Text] [Related]
4. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
6. Diabetes, use of metformin, and the risk of meningioma.
Seliger C; Meier CR; Becker C; Jick SS; Proescholdt M; Bogdahn U; Hau P; Leitzmann MF
PLoS One; 2017; 12(7):e0181089. PubMed ID: 28708856
[TBL] [Abstract][Full Text] [Related]
7. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial.
Tsilidis KK; Capothanassi D; Allen NE; Rizos EC; Lopez DS; van Veldhoven K; Sacerdote C; Ashby D; Vineis P; Tzoulaki I; Ioannidis JP
Diabetes Care; 2014 Sep; 37(9):2522-32. PubMed ID: 24898303
[TBL] [Abstract][Full Text] [Related]
8. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
9. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
Simeone JC; Quilliam BJ
Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes mellitus, glycaemic control, associated therapies and risk of rheumatoid arthritis: a retrospective cohort study.
Zemedikun DT; Gokhale K; Chandan JS; Cooper J; Lord JM; Filer A; Falahee M; Nirantharakumar K; Raza K
Rheumatology (Oxford); 2021 Dec; 60(12):5567-5575. PubMed ID: 33590842
[TBL] [Abstract][Full Text] [Related]
11. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes.
Erkinantti S; Marttila M; Sund R; Arffman M; Urpilainen E; Puistola U; Hautakoski A; Karihtala P; Läärä E; Jukkola A
Clin Colorectal Cancer; 2021 Jun; 20(2):e113-e119. PubMed ID: 33279415
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
[TBL] [Abstract][Full Text] [Related]
13. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
14. Metformin and the risk of head and neck cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
[TBL] [Abstract][Full Text] [Related]
15. Association between metformin use and risk of prostate cancer and its grade.
Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
[TBL] [Abstract][Full Text] [Related]
16. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
[TBL] [Abstract][Full Text] [Related]
17. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
18. Association Between Stroke Risk and Metformin Use in Hemodialysis Patients With Diabetes Mellitus: A Nested Case-Control Study.
Chien LN; Chou CL; Chen HH; Kao CC; Lin YC; Wu YL; Chen JS; Chen LY; Fang TC
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29146610
[TBL] [Abstract][Full Text] [Related]
19. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
20. Metformin and the risk of renal cell carcinoma: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Eur J Cancer Prev; 2017 May; 26(3):257-262. PubMed ID: 26945286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]